Published in Clin Diagn Lab Immunol on November 01, 2005
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother (2008) 1.38
Quantitative real-time PCR is not more sensitive than "conventional" PCR. J Clin Microbiol (2008) 1.32
Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J Clin Microbiol (2010) 1.17
High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons. J Mol Diagn (2009) 0.99
Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev (2014) 0.99
Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction. Clin Med Insights Oncol (2010) 0.80
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother (1994) 6.45
Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis (2001) 6.32
Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol (1997) 5.86
Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis (2004) 3.63
A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol (1995) 3.60
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis (2004) 3.06
Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol (2000) 3.02
Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol (1998) 2.92
Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob Agents Chemother (2001) 2.65
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (1996) 2.52
Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol (2002) 2.31
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother (2002) 2.30
Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol (1995) 2.28
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20
The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) (1993) 2.18
Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis (2001) 2.15
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother (2001) 2.13
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood (2003) 2.01
Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses (1997) 1.98
Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol (1995) 1.96
Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol (1999) 1.77
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother (2002) 1.72
The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun (2005) 1.68
Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis (2000) 1.47
Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol (2000) 1.40
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob Agents Chemother (1991) 1.39
Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol (2000) 1.35
Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis (1999) 1.33
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol (2001) 1.27
Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother (2004) 1.21
PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients. J Clin Pathol (1998) 1.13
Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest (2002) 1.09
Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun (1998) 1.08
Saperconazole therapy in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (1992) 1.03
Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (2000) 0.99
Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis. J Infect Dis (2002) 0.97
Molecular approaches for the diagnosis and epidemiological investigation of Aspergillus infection. Mycoses (1999) 0.80
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82
Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study. Clin Infect Dis (2013) 2.28
Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA (2012) 2.27
Use of ethanol locks to prevent recurrent central line sepsis. J Infect (2004) 1.69
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther (2009) 1.49
Peritonsillar infection in Christchurch 2006-2008: epidemiology and microbiology. N Z Med J (2011) 1.46
Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol (2003) 1.41
Cutaneous myiasis due to Dermatobia hominis (the human botfly) in a New Zealand traveller returned from South America. N Z Med J (2009) 1.39
The scent of Mycobacterium tuberculosis--part II breath. Tuberculosis (Edinb) (2009) 1.27
Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. N Z Med J (2002) 1.23
Contamination of Qiagen DNA extraction kits with Legionella DNA. J Clin Microbiol (2003) 1.22
Recurrent breast abscess caused by Gordonia bronchialis in an immunocompetent patient. J Clin Microbiol (2005) 1.17
The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2008) 1.08
Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol (2008) 1.06
2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulm Med (2010) 1.05
Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One (2011) 0.97
Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism (2005) 0.96
Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect (2009) 0.93
Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects. Eur J Nutr (2007) 0.93
Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am J Clin Nutr (2008) 0.92
Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem (2004) 0.90
Betaine and secondary events in an acute coronary syndrome cohort. PLoS One (2012) 0.90
Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints. ANZ J Surg (2004) 0.88
Free and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion. J Antimicrob Chemother (2002) 0.88
Protein binding of cefazolin is saturable in vivo both between and within patients. Br J Clin Pharmacol (2007) 0.87
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney Int (2002) 0.87
Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults. PLoS One (2013) 0.87
Inter- and intra-individual variations in normal urinary glycine betaine excretion. Clin Biochem (2007) 0.87
Campylobacter fetus-associated epidural abscess and bacteremia. J Clin Microbiol (2009) 0.86
Betaine analogues alter homocysteine metabolism in rats. Int J Biochem Cell Biol (2004) 0.85
Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. Cardiovasc Diabetol (2012) 0.84
Plasma and urine betaine and dimethylglycine variation in healthy young male subjects. Clin Biochem (2009) 0.83
Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic. Clin Biochem (2007) 0.82
Real-time detection of common microbial volatile organic compounds from medically important fungi by Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS). J Microbiol Methods (2005) 0.82
An abnormal urinary excretion of glycine betaine may persist for years. Clin Biochem (2007) 0.81
Betaine excretion correlates with plasma homocysteine when plasma lipids are elevated. Clin Biochem (2011) 0.80
An audit of venous duplex ultrasonography in patients with lower limb cellulitis. N Z Med J (2011) 0.80
Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology (2005) 0.78
Plasma betaine concentrations correlate with plasma cortisol but not with C-reactive protein in an elderly population. Clin Chem Lab Med (2012) 0.78
The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments. PLoS One (2012) 0.77
Prevalence of concurrent deep vein thrombosis in patients with lower limb cellulitis: a prospective cohort study. BMC Infect Dis (2013) 0.76
Assessment of potential causes of falsely positive Mycobacterium tuberculosis breath test. Tuberculosis (Edinb) (2013) 0.76
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovasc Drugs Ther (2014) 0.76
Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother (2004) 0.76
Assessment of antimicrobial activity of hydrophilic betaines in osmotically stressed bacteria. Antonie Van Leeuwenhoek (2003) 0.75
Atypical pneumonia--time to breathe new life into a useful term? Lancet Infect Dis (2009) 0.75
Enhanced detection of Legionnaires' disease by PCR testing of induced sputum and throat swabs. Eur Respir J (2013) 0.75
Fibrates plus betaine: a winning combination? N Z Med J (2010) 0.75
Staphylococcus aureus Carriage in a New Zealand Primary School: A Cohort Study. Pediatr Infect Dis J (2017) 0.75
Dimethylglycine supplementation does not affect plasma homocysteine concentrations in pre-dialysis chronic renal failure patients. Clin Biochem (2004) 0.75